Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

THOMAS WESTBROOK, PhD

Baylor College of Medicine
Microenvironment response disparities of metastatic TNBC to multi-tyrosine kinase inhibition

MICHELLE WILLIAMS, PHD

UPMC Hillman Cancer Center, University of Pittsburgh
Presented in memory of Erica Griffiths
Targeting the Tumor Secretome to Reverse Immune Exclusion in Breast Cancer Liver Metastases

Fei Xing, PhD

Wake Forest University
Treating breast cancer brain metastasis with immune checkpoint inhibitor and c-Met targeting agent

Jing Yang, PhD

University of California, San Diego
Overcoming therapy resistance in TNBC metastases through targeted inhibition of Periostin

Wen-Hsuan Yang, PhD

Cold Spring Harbor Laboratory
Presented by Philadelphia Metsquerade in honor of Jacquie Reynolds Beck and Kerry O’Riordan McAdam
Targeting metabolic symbiosis in the breast cancer brain metastasis tumor microenvironment

Amy Yee

Tufts University School of Medicine
Presented by To Heck With Cancer partnering with RadNet Management, in memory of Julia Heck
Cha1: A New Therapeutic Strategy for Triple Negative Breast Cancers and Brain Metastases

ELIZABETH YEH, PhD

Medical University of South Carolina
Application of a Connexin 43 (Cx43) Targeted Agent for the Treatment of Metastatic Breast Cancer

STEPHANIE YOON, MD

City of Hope
Presented by To Heck With Cancer partnering with RadNet Management, in memory of Julia Heck
Biomarker-Driven Approaches to Optimize Craniospinal Irradiation for Breast Cancer Leptomeningeal Disease

Dihua Yu, PhD

The University of Texas
Presented In loving memory of Tiffany Foust and Kriss Fierro by Monica Hill’s Be Bold and Behold
Impeding Breast Cancer Brain Metastasis by Blocking CCR2+ Myeloid Cell Infiltration

Min Yu, PhD

The University of Maryland School of Medicine, Baltimore
Presented in honor of Tara Kuipers – Creator of #LightUpMBC Color Fun Run
Targeting IGFBP3 signaling as a novel therapy for ESR1-Y537S mutant driven bone metastasis

Dihua Yu, MD, PhD

The University of Texas MD Anderson Cancer Center
Identification and Targeting of Kinases Involved in Breast Cancer Brain Metastasis

DIHUA YU, MD, PhD

MD Anderson Cancer Center
Combating Breast Cancer Brain Metastasis by Blocking CDK5 Driver Kinase Function